Key result
Echocardiographic assessment of epicardial adipose tissue serves as a reliable, non-invasive marker of visceral adiposity and its associated cardiovascular and metabolic risks.
Why the study?
Visceral adipose tissue predicts unfavorable cardiovascular and metabolic risk, but existing methods to assess it have been limited.
Echocardiographic measurement of epicardial adipose tissue provides a reliable, non-invasive estimate of visceral adiposity and associated cardiometabolic risk.
Answers are grounded in this paper and cite their sources.
Echocardiographic epicardial fat assessment may mark visceral adiposity; leaves open prognostic value and clinical adoption pending validation.
Visceral adipose tissue predicts an unfavorable cardiovascular and metabolic risk profile in humans. Existing methods to assess visceral adipose tissue have been limited. Thus, echocardiographic assessment of epicardial adipose tissue as a marker of visceral adiposity was suggested. The technique has been shown to be a very reliable method and an excellent measure of visceral adiposity. In this article, epicardial adipose tissue's localization on the heart, function, method of assessment and reliability as a marker of visceral adiposity is briefly reviewed. Areas of the technique requiring further study are identified.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2020) conducted a review in Visceral adiposity. Echocardiographic assessment of epicardial adipose tissue was evaluated. Echocardiographic assessment of epicardial adipose tissue serves as a reliable, non-invasive marker of visceral adiposity and its associated cardiovascular and metabolic risks.
Synapse has enriched 10 related papers. Consider them for comparative context: